We have a heritage in Vector Control spanning more than 60 years and a team of over 50 people around the globe which support our activities in the fight against vector-borne disease. We continue to build on this long-term commitment and expertise in order to continue to provide solutions that protect people where they live, work and play.

This history of expertise is embedded into our 360° Vector Control approach, along with our portfolio and innovation capacity, commitment to training and education, advocacy, and partnerships.

Throughout this history, we have worked with vector control programs around the world, striving to help them achieve better results and to save lives.

It all started in 1923, when the Bayer scientist Wilhelm Roehl developed Germanin, a product to fight African sleeping sickness.

In 1934, another Bayer scientist Dr. Hans Andersag discovered Resochin, which is still one of the most important drugs for the treatment of malaria infection today. Over the years, Bayer scientists have pioneered the development of new insecticides which have been used widely in vector-borne disease control.

During the 1960s, we developed insecticides for use in indoor residual spray programs which were at the centre of the campaigns to eliminate malaria. This development continued into the 1970s and 1980s with the advent of carbamates such as bendiocarb and synthetic pyrethroids like deltamethrin and cyfluthrin, which are still used in vector control programs to this day.

In the near future, we will introduce new active ingredients and formulations to the market that will help to fight mosquitoes more cost-effectively; with greater impact against insecticide resistance and overall a greater impact on vector-borne disease.

We are committed to using this expertise in the fight against vector-borne diseases.